Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.67 |
| ▸ | MEN1 | O00255 | 7/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.67 |
| ▸ | MAPT | P10636 | 7/20 | 0.67 |
| ▸ | TP53 | P04637 | 6/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.67 |
| ▸ | HPGD | P15428 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.60 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31675988 | 1.00 | KDM4E (0.67) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL6666764 | 0.86 | CYP1B1 (0.60) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL380907 | 0.85 | ADORA3 (0.73) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL5133662 | 0.85 | NOX4 (0.73) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL7660030 | 0.84 | NOX4 (0.76) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL38650680 | 0.84 | ABCG2 (0.83) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL28536757 | 0.84 | ABCG2 (0.83) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL21581945 | 0.83 | ABCG2 (0.60) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL5964713 | 0.83 | KDM4E (0.62) | KDM4ECYP3A4MEN1KMT2AMAPT | |
| SCHEMBL28757172 | 0.83 | ADORA3 (0.60) | KDM4ECYP3A4MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109336469-B | SBS modified asphalt mixture and preparation method thereof | 湖北津泰环保科技有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-101898967-A | Synthesis method of 5-methoxyflavonol | CINKATE PHARMACEUTICAL CHEMICAL INTERMEDIATES SHANGHAI CO LTD | 2010-12-01 | — | — | CN | claimed |
| CN-1837202-B | Flavonols with blood-fat-lowering effect | UNIV PLA 2ND MILITARY MEDICAL | 2010-08-18 | — | — | CN | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| US-5626883-A | VITAMIN C SUPPLEMENTS FOR IMMUNOLOGY | METAGENICS, INC. | 1997-05-06 | — | — | US | claimed |
| EP-4536210-A2 | FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS | Mayo Foundation for Medical Education and Research (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023244619-A2 | FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2023-12-21 | — | — | WO | disclosed |
| CN-113072527-B | Potato ring rot pathogen resistant quercetin derivative and synthesis method and application thereof | 山西大学 | 2023-03-10 | — | — | CN | disclosed |
| CN-110446486-B | Novel antioxidants for cosmetic and pharmaceutical compositions containing glycerol alkyl ethers | 赛成公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-113072527-A | Potato ring rot pathogen resistant quercetin derivative and synthesis method and application thereof | 山西大学 | 2021-07-06 | — | — | CN | disclosed |
| CN-109336469-B | SBS modified asphalt mixture and preparation method thereof | 湖北津泰环保科技有限公司 | 2021-06-08 | — | — | CN | disclosed |
| US-20030125264-A1 | Methods For Treating Wounds | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-03 | — | — | US | disclosed |
| US-6555523-B1 | Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus | CASCADE ESTATES LTD. (MU) | 2003-04-29 | — | — | US | disclosed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | disclosed |
| US-5626883-A | VITAMIN C SUPPLEMENTS FOR IMMUNOLOGY | METAGENICS, INC. | 1997-05-06 | — | — | US | disclosed |
| WO-1995028084-A1 | ASCORBIC ACID COMPOSITION PROVIDING ENHANCED HUMAN IMMUNE SYSTEM ACTIVITY | METAGENICS, INC. (US) | 1995-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125264-A1 | Methods For Treating Wounds | FGF2, MMP1, FIBP | KDM4E 2309/4885CYP3A4 3010/4885MEN1 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.